Skip to content

Effect of low-molecular-weight heparin on pregnancy outcomes in Chinese women with recurrent implantation failure undergoing frozen embryo transfer: an open-label randomized controlled trial

Effect of low-molecular-weight heparin on pregnancy outcomes in Chinese women with recurrent implantation failure undergoing frozen embryo transfer: an open-label randomized controlled tria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121866
Enrollment
Unknown
Registered
2026-04-06
Start date
2026-04-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failure in frozen embryo transfer cycles

Interventions

Experimental group:Luteal support + low molecular weight heparin

Sponsors

The Second Hospital, Cheeloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: 1. Egg retrieval age = 4BC; 4. At least 3 attempts of fresh/frozen embryo transfer have failed; 5. Participants are willing to cooperate with the research plan and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. One of the spouses has chromosomal abnormalities; 2. Un-treated submucosal uterine fibroids or endometrial polyps; 3. History of autoimmune diseases, such as antiphospholipid syndrome, Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, etc.; 4. Thin endometrium before transplantation (< 7mm); 5. Medical contraindications for LMWH or ART and/or pregnancy; 6. Women currently taking any anticoagulant drugs (such as aspirin); 7. History of intrauterine adhesions; 8. Ultrasound showing untreated tubal hydrops; 9. Embryos to be thawed and transplanted come from frozen stored oocytes sources, or have undergone secondary freezing storage; 10. History of recurrent spontaneous abortion (RSA); 11. FET after pre-implantation genetic testing (PGT).

Design outcomes

Primary

MeasureTime frame
Live birth rate;

Secondary

MeasureTime frame
Clinical pregnancy rate;Biochemical pregnancy rate;Embryo implantation rate;Early miscarriage rate;Ectopic pregnancy rate;Complication rate during pregnancy;Perinatal complication rate;Fetal birth weight;Congenital malformation;Other adverse reactions;

Countries

China

Contacts

Public ContactCui Linlin

The Second Hospital, Cheeloo College of Medicine, Shandong University

fdclear3@126.com+86 531 8587 5930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026